Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, Randomized Controlled Trial

Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double‐Blind, Parallel‐Group, Randomized Controlled Trial

Abstract This study aimed to assess the efficacy and safety of a combination therapy of Allisartan Isoproxil 240 mg and Amlodipine 5 mg (ALI/AML) compared to AML 5 mg monotherapy in patients with mild‐to‐moderate essential hypertension. In this phase III, multicenter, double‐blind, parallel‐group, r...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjie Chi, Xin Zhang, Shumei Ma, Gang Pan, Xiaojuan Lian, Yan Chen, Haotian Pei, Zichen Liu, Xiangmin Lin
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:The Journal of Clinical Hypertension
Subjects:
allisartan
amlodipine
hypertension
Online Access:https://doi.org/10.1111/jch.14955
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items